{
  "resourceType" : "MedicationStatement",
  "id" : "exa-medication-statement-caelyx",
  "meta" : {
    "profile" : ["https://www.vision-zero-oncology.de/fhir/StructureDefinition/pr-medication-statement"]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationStatement</b><a name=\"exa-medication-statement-caelyx\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationStatement &quot;exa-medication-statement-caelyx&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-pr-medication-statement.html\">MedicationStatement</a></p></div><p><b>status</b>: active</p><p><b>medication</b>: Doxorubicin <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;canonical=http://fhir.de/CodeSystem/bfarm/atc\">Atc</a>#L01DB01)</span></p><p><b>subject</b>: <a href=\"https://simplifier.net/resolve?scope=de.basisprofil.r4@1.4.0&amp;canonical=http://fhir.org/packages/de.basisprofil.r4/Patient/example\">Patient/example</a></p><p><b>effective</b>: 2020-01-02 09:30:00+0100</p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Text</b></td><td><b>Timing</b></td><td><b>Route</b></td></tr><tr><td>*</td><td>Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion</td><td>Once per 4 weeks</td><td>Intravenous use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (standardterms.edqm.eu#20045000)</span></td></tr></table></div>"
  },
  "status" : "active",
  "medicationCodeableConcept" : {
    "coding" : [{
      "system" : "http://fhir.de/CodeSystem/bfarm/atc",
      "code" : "L01DB01",
      "display" : "Doxorubicin"
    }]
  },
  "subject" : {
    "reference" : "Patient/example"
  },
  "effectiveDateTime" : "2020-01-02T09:30:00+01:00",
  "dosage" : [{
    "text" : "Doxorubicin (Caelyx) 50 mg je Quadratmeter Koerperoberflaeche alle vier Wochen per intravenoeser Tropfinfusion",
    "timing" : {
      "repeat" : {
        "frequency" : 1,
        "period" : 4,
        "periodUnit" : "wk"
      }
    },
    "route" : {
      "coding" : [{
        "system" : "http://standardterms.edqm.eu",
        "code" : "20045000",
        "display" : "Intravenous use"
      }]
    }
  }]
}